Energy Requirements for Maintenance and Growth of Male Saanen Goat Kids

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

CONTRIBUTION OF BASAL AND AERIAL TILLERS IN DYNAMICS OF HERBAGE PRODUCTION OF SIGNALGRASS AFTER GRAZING DEFERRED

During the spring, the understanding of regrowth in basal and aerial tillers of deferred pasture in winter it is necessary. Thus, the objective was to evaluate the morphogenesis and herbage accumulation during spring in Brachiaria decumbens cv. Basilisk (signalgrass) pasture used under deferred grazing in winter. The basal and aerial tillers in same pasture were evaluated. The signalgrass was managed with grazing cattle and with an average height of 25 cm. The randomized block design with three replications was adopted. The leaf appearance rate, phyllochron and the numbers of expanded, expanding and live leaves did not differ between basal and aerial tillers. The aerial tiller possessed lower rates of leaf senescence, of leaf elongation and of stem elongation, as well as lower number of dead leaf and stem and leaf lamina lengths, compared to basal tiller. The leaf lifespan was higher in aerial tillers than at basal. The basal tiller also contributed to higher rates of tissue growth and forage accumulation in pasture when compared to aerial tiller. After deferred grazing during the spring, the aerial tiller has low participation in forage production of signalgrass pasture.

Human follicle stimulating hormone (hFSH) and thyroxine (T4) in survival maintenance and in vitro growth promotion of caprine preantral follicles

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Mineral requirements for growth and maintenance of F-1 Boer x Saanen male kids

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Adalimumab for maintenance therapy for one year in Crohn's disease: results of a Latin American single-center observational study

Adalimumab is a fully-human antibody that inhibits TNF alpha, with a significant efficacy for long-term maintenance of remission. Studies with this agent in Latin American Crohn's disease patients are scarce. The objective of this study was to outline clinical remission rates after 12 months of adalimumab therapy for Crohn's disease patients. Retrospective, single-center, observational study of a Brazilian case series of Crohn's disease patients under adalimumab therapy. Variables analyzed: demographic data, Montreal classification, concomitant medication, remission rates after 1, 4, 6 and 12 months. Remission was defined as Harvey-Bradshaw Index ≤ 4, and non-responder-imputation and last-observation-carried-forward analysis were used. The influence of infliximab on remission rates was analyzed by Fischer and Chi-square tests (P<0.05). Fifty patients, with median age of 35 years at therapy initiation, were included. Remission rates after 12 months of therapy were 54% under non-responder-imputation and 88% under last-observation-carried-forward analysis. After 12 months, remission on patients with previous infliximab occurred in 69.23% as compared to 94.59% in infliximab-naïve patients (P = 0.033). Adalimumab was effective in maintaining clinical remission after 12 months of therapy, with an adequate safety profile, and was also more effective in infliximab naïve patients.

Techniques to improve the maintenance of a laboratory colony of Nyssomyia neivai (Diptera: Psychodidae)

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Anthropometric indicators predict metabolic syndrome diagnosis in maintenance hemodialysis patients

Obesity has been considered the key in metabolic syndrome (MetS) development, and fat accumulation may be responsible for the occurrence of metabolic abnormalities in hemodialysis patients. The use of gold-standard methods to evaluate obesity is limited, and anthropometric measures may be the simplest methods. However, no study has investigated the association between anthropometric indexes and MetS in these patients. Therefore, the aim was to determine which anthropometric indexes had the best association and prediction for MetS in patients undergoing hemodialysis. Cross-sectional study that included patients older than 18 years, undergoing hemodialysis for at least 3 months. Patients with liver disease and cancer or those receiving corticosteroids or antiretroviral therapy were excluded. Diagnostic criteria from Harmonizing Metabolic Syndrome were used for the diagnosis of MetS. Anthropometric indexes evaluated were body mass index (BMI); percent standard of triceps skinfold thickness and of middle arm muscle circumference; waist circumference (WC); sagittal abdominal diameter; neck circumference; waist-to-hip, waist-to-thigh, and waist-to-height ratios; sagittal index; conicity index; and body fat percentage. Ninety-eight patients were included, 54.1% male, and mean age was 57.8 ± 12.9 years. The prevalence of MetS was 74.5%. Individuals with MetS had increased accumulation of abdominal fat and general obesity. Waist-to-height ratio was the variable independently associated with MetS diagnosis (odds ratio, 1.21; 95% confidence interval, 1.09-1.34; P < .01) and that better predicts MetS, followed by WC and BMI (area under the curve of 0.840, 0.836, and 0.798, respectively, P < .01). Waist-to-height ratio was the best anthropometric predictor of MetS in maintenance hemodialysis patients.